Literature DB >> 18347614

The roles of MAPKs in disease.

Michael C Lawrence1, Arif Jivan, Chunli Shao, Lingling Duan, Daryl Goad, Elma Zaganjor, Jihan Osborne, Kathleen McGlynn, Steve Stippec, Svetlana Earnest, Wei Chen, Melanie H Cobb.   

Abstract

MAP kinases transduce signals that are involved in a multitude of cellular pathways and functions in response to a variety of ligands and cell stimuli. Aberrant or inappropriate functions of MAPKs have now been identified in diseases ranging from cancer to inflammatory disease to obesity and diabetes. In many cell types, the MAPKs ERK1/2 are linked to cell proliferation. ERK1/2 are thought to play a role in some cancers, because mutations in Ras and B-Raf, which can activate the ERK1/2 cascade, are found in many human tumors. Abnormal ERK1/2 signaling has also been found in polycystic kidney disease, and serious developmental disorders such as cardio-facio-cutaneous syndrome arise from mutations in components of the ERK1/2 cascade. ERK1/2 are essential in well-differentiated cells and have been linked to long-term potentiation in neurons and in maintenance of epithelial polarity. Additionally, ERK1/2 are important for insulin gene transcription in pancreatic beta cells, which produce insulin in response to increases in circulating glucose to permit efficient glucose utilization and storage in the organism. Nutrients and hormones that induce or repress insulin secretion activate and/or inhibit ERK1/2 in a manner that reflects the secretory demand on beta cells. Disturbances in this and other regulatory pathways may result in the contribution of ERK1/2 to the etiology of certain human disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18347614     DOI: 10.1038/cr.2008.37

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  93 in total

1.  Tetraspanin CD151 regulates growth of mammary epithelial cells in three-dimensional extracellular matrix: implication for mammary ductal carcinoma in situ.

Authors:  Vera Novitskaya; Hanna Romanska; Marwa Dawoud; J Louise Jones; Fedor Berditchevski
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

2.  Two hydrophobic residues can determine the specificity of mitogen-activated protein kinase docking interactions.

Authors:  A Jane Bardwell; Lee Bardwell
Journal:  J Biol Chem       Date:  2015-09-14       Impact factor: 5.157

3.  Physical Activity in the Prevention and Therapy of Breast Cancer.

Authors:  Christine Graf; Nicolas Wessely
Journal:  Breast Care (Basel)       Date:  2010-12-08       Impact factor: 2.860

4.  Selectivity of docking sites in MAPK kinases.

Authors:  A Jane Bardwell; Erlynn Frankson; Lee Bardwell
Journal:  J Biol Chem       Date:  2009-02-05       Impact factor: 5.157

5.  Characterization of adipocyte stress response pathways during hibernation in thirteen-lined ground squirrels.

Authors:  Andrew N Rouble; Shannon N Tessier; Kenneth B Storey
Journal:  Mol Cell Biochem       Date:  2014-04-29       Impact factor: 3.396

6.  Structural and functional analysis of phosphorylation-specific binders of the kinase ERK from designed ankyrin repeat protein libraries.

Authors:  Lutz Kummer; Petra Parizek; Peter Rube; Bastian Millgramm; Anke Prinz; Peer R E Mittl; Melanie Kaufholz; Bastian Zimmermann; Friedrich W Herberg; Andreas Plückthun
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-27       Impact factor: 11.205

Review 7.  MEK1/2 Inhibitors: Molecular Activity and Resistance Mechanisms.

Authors:  Pui-Kei Wu; Jong-In Park
Journal:  Semin Oncol       Date:  2015-09-24       Impact factor: 4.929

8.  Computational prediction and experimental verification of new MAP kinase docking sites and substrates including Gli transcription factors.

Authors:  Thomas C Whisenant; David T Ho; Ryan W Benz; Jeffrey S Rogers; Robyn M Kaake; Elizabeth A Gordon; Lan Huang; Pierre Baldi; Lee Bardwell
Journal:  PLoS Comput Biol       Date:  2010-08-26       Impact factor: 4.475

9.  Utilizing ras signaling pathway to direct selective replication of herpes simplex virus-1.

Authors:  Weihong Pan; Vidya Bodempudi; Tuba Esfandyari; Faris Farassati
Journal:  PLoS One       Date:  2009-08-04       Impact factor: 3.240

10.  Interleukin-32 promotes osteoclast differentiation but not osteoclast activation.

Authors:  Guillaume Mabilleau; Afsie Sabokbar
Journal:  PLoS One       Date:  2009-01-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.